Date: October 7, 2019
Time: 12:00 am - 12:00 am
Location: Nexus Building, University of Leeds, Discovery Way, Leeds, LS2 3AA
North East
Leeds Evening Seminar
Speakers: Dr Adrian Brown & Dr Peter Finan

Itecho Health is a young, dynamic company established to develop digital health applications in chronic (long-term) disease.  Dr Adrian Brown is CEO of Itecho Health and Project Lead. Having qualified with a medical degree from University of Newcastle, Adrian pursued postgraduate work in obstetrics and gynaecology.  During 10 years as a NHS consultant in Public Health in London, he became keenly interested in the commercial application of digital technology to solving health problems and was a lead founder of mHealth futures in April 2014

Founded in Maryland, USA in 2010, Epidarex Capital invests in early stage, high growth companies primarily in the health and life science sectors. It currently has 19 companies in its portfolio. In 2013, it entered the UK and in 2014 unveiled from its Edinburgh base, a new £47.5m fund dedicated to UK start-ups including university spin-outs.  Dr Peter Finan who joined Epidarex Capital as a Venture Partner in 2014, is an alumnus of University of Leeds from which HEI he holds a BSc and PhD in Biochemistry and Molecular Biology respectively. Prior to joining Epidarex, he was Global Head of the Respiratory Disease Area and Site Head for the Novartis Institute of BioMedical Research in the United Kingdom.

Venue: Nexus Building

The University of Leeds has a strong background in commercialisation of the academic research base with an unrelenting focus on collaboration.  As part of this strategy, in the Spring of 2019, it opened on the University’s campus, the Nexus Building a state of the art innovation centre spanning more than  6,000 square metres over six floors.    The Nexus Building aims to bring together a vibrant community of innovators, designers and creators, supported by state-of-the-art facilities as well as a dedicated commercialisation team who will work proactively with businesses to identify and create effective research partnerships.